Europe precision medicine Market - Global Industry Analysis

Europe precision medicine Market By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technologies), By Application (Oncology, CNS, Immunology, Respiratory, Other Applications), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 11-May-2022 Category: Pharmaceutical Report Format : PDF Pages: 175 Report Code: ZMR-2578 Status : Published

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

Industry Prospective:

The global Europe precision medicine market was worth around USD 14,926.5 million in 2021 and is estimated to grow to about USD 27469 million by 2028, with a compound annual growth rate (CAGR) of approximately 10.7 percent over the forecast period. The report analyzes the Europe precision medicine market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Europe precision medicine market.

Europe precision medicine Market: Overview

Precision medicine has gained popularity across the world and this trend is anticipated to be prominent in the European region as well. –Increasing prevalence of chronic diseases, rising geriatric population, high research and development activity, and presence of key precision medicine manufacturers are some of the major factors that drive the Europe precision medicine market potential.

Increasing investments in healthcare infrastructure will further bolster the Europe precision medicine market potential in the long run. Rising instances of cancer are also projected to provide an impetus to the Europe precision medicine market growth through 2028.

However, the high costs associated with maintenance and installation of precision medical devices are expected to have a hindering effect on the global Europe precision medicine market growth over the forecast period.

COVID-19 Impact:

The COVID-19 pandemic had led to an increase in focus on the use of precision medicine owing to its high efficacy in safeguarding people from non-communicable diseases. Precision medicine is mainly used for cancers and diabetes the patients do not contract COVID-19. The demand for the same was high in the pandemic.

However, the Europe precision medicine market did not grow to its full potential despite high demand owing to changing world situations under the lockdowns that were imposed to contain the spread of coronavirus infections on a global scale.

The Europe precision medicine market is expected to see immense potential in the post-pandemic era as the healthcare technologies advance and precision medicine becomes more cost-effective and affordable for healthcare providers as well as patients.

Global Europe precision medicine Market

Europe precision medicine Market: Growth Drivers

Increasing Research and Development Activity

There have been substantial advancements in the global healthcare industry and this trend is anticipated to boost the Europe precision medicine market potential over the forecast period. As the prevalence of chronic diseases is increasing and the demand for better treatment and diagnosis as well, the Europe precision medicine market is expected to see high demand. Increasing investments in research and development by healthcare companies and governments alike are expected to be prominent trends driving the Europe precision medicine market potential through 2028.

Europe precision medicine Market: Restraints

High Installation and Maintenance Costs to Hamper growth

Precision medicine requires special equipment which is high in cost and is also costly to install and maintain and this factor alone is anticipated to have a major hindering effect on the Europe precision medicine market growth over the forecast period. Europe precision medicine companies are focusing on finding more affordable solutions to boost the adoption of precision medicine in Europe.

Global Europe precision medicine Market: Segmentation

The global Europe precision medicine market is segregated based on technology, application, and region.

By Application, the Europe precision medicine market is segmented into Oncology, CNS, Immunology, Respiratory, and Other Applications. The oncology segment is projected to be the most lucrative in the Europe precision medicine market landscape over the forecast period. Increasing demand for novel treatments for cancer and rising instances of cancer will majorly shape the growth in this segment through 2028.

Recent Developments

In November 2016 – International Consortium for Personalized Medicine, ICPerMed was launched by European and international members to advance research and bolster the use of personalized medicine in the European region and across the world.

Regional Landscape

Europe is anticipated to see high demand for precision medicine owing to rising investments in the healthcare sector to advance healthcare facilities and provide better treatment opportunities. Increasing support from government initiatives to boost the adoption of precision medicine will also majorly influence Europe’s precision medicine market potential through 2028. The United Kingdom holds a major market share in the Europe precision medicine industry landscape and is expected to maintain this stance over the forecast period as well. Increasing research activity and the rising use of genome analysis are other factors that will drive the market potential in the United Kingdom through 2028. France, Germany, Spain, and Italy are also expected to be highly lucrative markets owing to increasing investments in the advancement of healthcare infrastructure. Increasing demand for better treatment and diagnosis will be a major trend prevalent in all countries in Europe.

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companies upon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact research needs.

Competitive Landscape

Some of the main competitors dominating the global Europe precision medicine market include - 23andMe, Allscripts Healthcare LLC, Astarte Medical, AstraZeneca PLC, Biogen, Bristol-Myers Squibb, F Hoffmann-La Roche AG, Kailos Genetics Inc., Laboratory Corporation of America Holdings, Medtronic PLC, Myriad Genetics Inc., Novartis AG, Pfizer Inc., Qiagen NV, Quest Diagnostics, Thermo Fisher Scientific Inc.

Global Europe precision medicine market is segmented as follows:

By Technology

Big Data Analytics
Bioinformatics
Gene Sequencing
Drug Discovery
Companion Diagnostics
Other Technologies

By Application

Oncology
CNS
Immunology
Respiratory
Other Applications

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
  - 1.3.1 Market Research Type
  - 1.3.2 Market research methodology
Chapter 2. Executive Summary
- 2.1 Global Europe precision medicine Market, (2022 - 2028) (USD Million)
- 2.2 Global Europe precision medicine Market : snapshot
Chapter 3. Global Europe precision medicine Market - Industry Analysis
- 3.1 Europe precision medicine Market: Market Dynamics
- 3.2 Market Drivers
  - 3.2.1 Increasing Research and Development Activity
- 3.3 Market Restraints
  - 3.3.1. High Installation and Maintenance Costs to Hamper growth
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
  - 3.7.1 Market attractiveness analysis By Technology
  - 3.7.2 Market attractiveness analysis By Application
Chapter 4. Global Europe precision medicine Market- Competitive Landscape
- 4.1 Company market share analysis
  - 4.1.1 Global Europe precision medicine Market: company market share, 2021
- 4.2 Strategic development
  - 4.2.1 Acquisitions & mergers
  - 4.2.2 New Product launches
  - 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
Chapter 5. Global Europe precision medicine Market - Technology Analysis
- 5.1 Global Europe precision medicine Market overview: By Technology
  - 5.1.1 Global Europe precision medicine Market share, By Technology, 2021 and 2028
- 5.2 Big Data Analytics
  - 5.2.1 Global Europe precision medicine Market by Big Data Analytics, 2022 - 2028 (USD Million)
- 5.3 Bioinformatics
  - 5.3.1 Global Europe precision medicine Market by Bioinformatics, 2022 - 2028 (USD Million)
- 5.4 Gene Sequencing
  - 5.4.1 Global Europe precision medicine Market by Gene Sequencing, 2022 - 2028 (USD Million)
- 5.5 Drug Discovery
  - 5.5.1 Global Europe precision medicine Market by Drug Discovery, 2022 - 2028 (USD Million)
- 5.6 Companion Diagnostics
  - 5.6.1 Global Europe precision medicine Market by Companion Diagnostics, 2022 - 2028 (USD Million)
- 5.7 Other Technologies
  - 5.7.1 Global Europe precision medicine Market by Other Technologies, 2022 - 2028 (USD Million)
Chapter 6. Global Europe precision medicine Market - Application Analysis
- 6.1 Global Europe precision medicine Market overview: By Application
  - 6.1.1 Global Europe precision medicine Market share, By Application, 2021 and 2028
- 6.2 Oncology
  - 6.2.1 Global Europe precision medicine Market by Oncology, 2022 - 2028 (USD Million)
- 6.3 CNS
  - 6.3.1 Global Europe precision medicine Market by CNS, 2022 - 2028 (USD Million)
- 6.4 Immunology
  - 6.4.1 Global Europe precision medicine Market by Immunology, 2022 - 2028 (USD Million)
- 6.5 Respiratory
  - 6.5.1 Global Europe precision medicine Market by Respiratory, 2022 - 2028 (USD Million)
- 6.6 Other Applications
  - 6.6.1 Global Europe precision medicine Market by Other Applications, 2022 - 2028 (USD Million)
Chapter 7. Europe precision medicine Market - Regional Analysis
- 7.1 Global Europe precision medicine Market Regional Overview
- 7.2 Global Europe precision medicine Market Share, by Region, 2021 & 2028 (USD Million)
- 7.3. North America
  - 7.3.1 North America Europe precision medicine Market, 2022 - 2028 (USD Million)
    - 7.3.1.1 North America Europe precision medicine Market, by Country, 2022 - 2028 (USD Million)
- 7.4 North America Europe precision medicine Market, by Technology, 2022 - 2028
  - 7.4.1 North America Europe precision medicine Market, by Technology, 2022 - 2028 (USD Million)
- 7.5 North America Europe precision medicine Market, by Application, 2022 - 2028
  - 7.5.1 North America Europe precision medicine Market, by Application, 2022 - 2028 (USD Million)
- 7.4. Europe
  - 7.4.2 Europe Europe precision medicine Market, 2022 - 2028 (USD Million)
    - 7.4.2.1 Europe Europe precision medicine Market, by Country, 2022 - 2028 (USD Million)
- 7.4 Europe Europe precision medicine Market, by Technology, 2022 - 2028
  - 7.4.1 Europe Europe precision medicine Market, by Technology, 2022 - 2028 (USD Million)
- 7.5 Europe Europe precision medicine Market, by Application, 2022 - 2028
  - 7.5.1 Europe Europe precision medicine Market, by Application, 2022 - 2028 (USD Million)
- 7.5. Asia Pacific
  - 7.5.3 Asia Pacific Europe precision medicine Market, 2022 - 2028 (USD Million)
    - 7.5.3.1 Asia Pacific Europe precision medicine Market, by Country, 2022 - 2028 (USD Million)
- 7.4 Asia Pacific Europe precision medicine Market, by Technology, 2022 - 2028
  - 7.4.1 Asia Pacific Europe precision medicine Market, by Technology, 2022 - 2028 (USD Million)
- 7.5 Asia Pacific Europe precision medicine Market, by Application, 2022 - 2028
  - 7.5.1 Asia Pacific Europe precision medicine Market, by Application, 2022 - 2028 (USD Million)
- 7.6. Latin America
  - 7.6.4 Latin America Europe precision medicine Market, 2022 - 2028 (USD Million)
    - 7.6.4.1 Latin America Europe precision medicine Market, by Country, 2022 - 2028 (USD Million)
- 7.4 Latin America Europe precision medicine Market, by Technology, 2022 - 2028
  - 7.4.1 Latin America Europe precision medicine Market, by Technology, 2022 - 2028 (USD Million)
- 7.5 Latin America Europe precision medicine Market, by Application, 2022 - 2028
  - 7.5.1 Latin America Europe precision medicine Market, by Application, 2022 - 2028 (USD Million)
- 7.7. The Middle-East and Africa
  - 7.7.5 The Middle-East and Africa Europe precision medicine Market, 2022 - 2028 (USD Million)
    - 7.7.5.1 The Middle-East and Africa Europe precision medicine Market, by Country, 2022 - 2028 (USD Million)
- 7.4 The Middle-East and Africa Europe precision medicine Market, by Technology, 2022 - 2028
  - 7.4.1 The Middle-East and Africa Europe precision medicine Market, by Technology, 2022 - 2028 (USD Million)
- 7.5 The Middle-East and Africa Europe precision medicine Market, by Application, 2022 - 2028
  - 7.5.1 The Middle-East and Africa Europe precision medicine Market, by Application, 2022 - 2028 (USD Million)
Chapter 8. Company Profiles
- 8.1 23andMe
  - 8.1.1 Overview
  - 8.1.2 Financials
  - 8.1.3 Product Portfolio
  - 8.1.4 Business Strategy
  - 8.1.5 Recent Developments
- 8.2 Allscripts Healthcare LLC
  - 8.2.1 Overview
  - 8.2.2 Financials
  - 8.2.3 Product Portfolio
  - 8.2.4 Business Strategy
  - 8.2.5 Recent Developments
- 8.3 Astarte Medical
  - 8.3.1 Overview
  - 8.3.2 Financials
  - 8.3.3 Product Portfolio
  - 8.3.4 Business Strategy
  - 8.3.5 Recent Developments
- 8.4 AstraZeneca PLC
  - 8.4.1 Overview
  - 8.4.2 Financials
  - 8.4.3 Product Portfolio
  - 8.4.4 Business Strategy
  - 8.4.5 Recent Developments
- 8.5 Biogen
  - 8.5.1 Overview
  - 8.5.2 Financials
  - 8.5.3 Product Portfolio
  - 8.5.4 Business Strategy
  - 8.5.5 Recent Developments
- 8.6 Bristol-Myers Squibb
  - 8.6.1 Overview
  - 8.6.2 Financials
  - 8.6.3 Product Portfolio
  - 8.6.4 Business Strategy
  - 8.6.5 Recent Developments
- 8.7 F Hoffmann-La Roche AG
  - 8.7.1 Overview
  - 8.7.2 Financials
  - 8.7.3 Product Portfolio
  - 8.7.4 Business Strategy
  - 8.7.5 Recent Developments
- 8.8 Kailos Genetics Inc.
  - 8.8.1 Overview
  - 8.8.2 Financials
  - 8.8.3 Product Portfolio
  - 8.8.4 Business Strategy
  - 8.8.5 Recent Developments
- 8.9 Laboratory Corporation of America Holdings
  - 8.9.1 Overview
  - 8.9.2 Financials
  - 8.9.3 Product Portfolio
  - 8.9.4 Business Strategy
  - 8.9.5 Recent Developments
- 8.10 Medtronic PLC
  - 8.10.1 Overview
  - 8.10.2 Financials
  - 8.10.3 Product Portfolio
  - 8.10.4 Business Strategy
  - 8.10.5 Recent Developments
- 8.11 Myriad Genetics Inc.
  - 8.11.1 Overview
  - 8.11.2 Financials
  - 8.11.3 Product Portfolio
  - 8.11.4 Business Strategy
  - 8.11.5 Recent Developments
- 8.12 Novartis AG
  - 8.12.1 Overview
  - 8.12.2 Financials
  - 8.12.3 Product Portfolio
  - 8.12.4 Business Strategy
  - 8.12.5 Recent Developments
- 8.13 Pfizer Inc.
  - 8.13.1 Overview
  - 8.13.2 Financials
  - 8.13.3 Product Portfolio
  - 8.13.4 Business Strategy
  - 8.13.5 Recent Developments
- 8.14 Qiagen NV
  - 8.14.1 Overview
  - 8.14.2 Financials
  - 8.14.3 Product Portfolio
  - 8.14.4 Business Strategy
  - 8.14.5 Recent Developments
- 8.15 Quest Diagnostics
  - 8.15.1 Overview
  - 8.15.2 Financials
  - 8.15.3 Product Portfolio
  - 8.15.4 Business Strategy
  - 8.15.5 Recent Developments
- 8.16 Thermo Fisher Scientific Inc.
  - 8.16.1 Overview
  - 8.16.2 Financials
  - 8.16.3 Product Portfolio
  - 8.16.4 Business Strategy
  - 8.16.5 Recent Developments

Table Of Figures

1. Market research Type
2. Market research methodology
3. Global Europe precision medicine Market, 2022 - 2028 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Europe precision medicine Market attractiveness, By Technology
6. Global Europe precision medicine Market attractiveness, By Application
7. Global Europe precision medicine Market share by Technology, 2022 and 2028 (USD Million)
8. Global Europe precision medicine Market by Big Data Analytics, 2022 - 2028 (USD Million)
9. Global Europe precision medicine Market by Bioinformatics, 2022 - 2028 (USD Million)
10. Global Europe precision medicine Market by Gene Sequencing, 2022 - 2028 (USD Million)
11. Global Europe precision medicine Market by Drug Discovery, 2022 - 2028 (USD Million)
12. Global Europe precision medicine Market by Companion Diagnostics, 2022 - 2028 (USD Million)
13. Global Europe precision medicine Market by Other Technologies, 2022 - 2028 (USD Million)
14. Global Europe precision medicine Market share by Application, 2022 and 2028 (USD Million)
15. Global Europe precision medicine Market by Oncology, 2022 - 2028 (USD Million)
16. Global Europe precision medicine Market by CNS, 2022 - 2028 (USD Million)
17. Global Europe precision medicine Market by Immunology, 2022 - 2028 (USD Million)
18. Global Europe precision medicine Market by Respiratory, 2022 - 2028 (USD Million)
19. Global Europe precision medicine Market by Other Applications, 2022 - 2028 (USD Million)
20. Global Europe precision medicine Market share, by Region, 2022 and 2028
21. North America Europe precision medicine Market, 2022 - 2028 (USD Million)
22. Europe Europe precision medicine Market, 2022 - 2028 (USD Million)
23. Asia Pacific Europe precision medicine Market, 2022 - 2028 (USD Million)
24. Latin America Europe precision medicine Market, 2022 - 2028 (USD Million)
25. The Middle-East and Africa Europe precision medicine Market, 2022 - 2028 (USD Million)

Table Of Tables

1. Global Europe precision medicine Market: Snapshot
2. Drivers of the Europe precision medicine Market: impact analysis
3. North America Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
4. North America Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
5. U.S. Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
6. U.S. Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
7. Canada Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
8. Canada Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
9. Europe Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
10. Europe Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
11. Germany Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
12. Germany Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
13. France Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
14. France Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
15. U.K. Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
16. U.K. Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
17. Italy Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
18. Italy Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
19. Spain Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
20. Spain Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
21. Rest of Europe Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
22. Rest of Europe Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
23. Asia Pacific Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
24. Asia Pacific Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
25. China Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
26. China Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
27. Japan Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
28. Japan Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
29. India Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
30. India Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
31. South Korea Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
32. South Korea Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
33. South-East Asia Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
34. South-East Asia Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
35. Rest of Asia Pacific Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
36. Rest of Asia Pacific Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
37. Latin America Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
38. Latin America Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
39. Brazil Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
40. Brazil Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
41. Mexico Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
42. Mexico Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
43. Rest of Latin America Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
44. Rest of Latin America Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
45. The Middle-East and Africa Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
46. The Middle-East and Africa Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
47. GCC Countries Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
48. GCC Countries Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
49. South Africa Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
50. South Africa Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)
51. Rest of Middle-East Africa Europe precision medicine Market revenue, By Technology, 2022 - 2028 (USD Million)
52. Rest of Middle-East Africa Europe precision medicine Market revenue, By Application, 2022 - 2028 (USD Million)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Europe Precision Medicine market. Zion Market Research has collected and analyzed key data belong to the global Europe Precision Medicine market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Europe Precision Medicine across the world has been calculated through primary and secondary research.

Zion Market Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Europe Precision Medicine industry. Primary research makes up the major source of data collection and validation.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening the secondary research findings
Further, develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
IDC and other relevant magazines
Internal and external proprietary databases, and relevant patent and regulatory databases
National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Europe Precision Medicine market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

Demographic data: Population split by segments
Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
Data is then cross-checked by an expert panel.

Choose License Type

Single User License

$4199.00 Multi User License

$5199.00 Enterprise Access License

$7199.00

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

RelatedNews

FrequentlyAsked Questions

Which key factors will influence Europe precision medicine market growth over 2022-2028?

Increasing focus on healthcare and rising demand for precision medicine in oncology are major trends that guide Europe precision medicine market growth.

What will be the value of the Europe precision medicine market during 2022-2028?

According to the Market Research report, the global Europe precision medicine market was worth about US$ 14,926.5 million in 2021 and is predicted to grow to around US$ 27469 million by 2028, with a compound annual growth rate (CAGR) of around 10.7 percent.

Which region will contribute notably towards the Europe precision medicine market value?

Which are the major players leveraging the Europe precision medicine market growth?

Some of the main competitors dominating the global Europe precision medicine market include -- 23andMe, Allscripts Healthcare LLC, Astarte Medical, AstraZeneca PLC, Biogen, Bristol-Myers Squibb, F Hoffmann-La Roche AG, Kailos Genetics Inc., Laboratory Corporation of America Holdings, Medtronic PLC, Myriad Genetics Inc., Novartis AG, Pfizer Inc., Qiagen NV, Quest Diagnostics, Thermo Fisher Scientific Inc.